Skip to content

TELEMEdical moNiTORing for COPD Patients

TELEMEdical moNiTORing for COPD Patients - Telementor COPD

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027961
Enrollment
218
Registered
2022-06-13
Start date
2022-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44

Interventions

Group 1: Intervention group: Standard care + receiving COPD package + using SaniQ app + automatic triaging of patient data + regular videoconferences with COPD nurses over a 12-month period. Group 2:

Sponsors

Deutsches Zentrum für Luft- und Raumfahrt (DLR)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: COPD patients (ICD 10 J44.0-J44.9); At least one documented exacerbation in the last 365 days; Present, signed patient participation form/consent form; Patients of participating study sites; Statutory health insurance; Own smartphone; Outpatient pulmonologist participates in TELEMENTOR (for inpatient enrollment); If the pneumology practice is unable to provide the COPD nurse, this function can also be carried out by the enrolling clinic, which is in close contact with the pneumology practice.

Exclusion criteria

Exclusion criteria: Patients with guardians; Patients with significant immobility as assessed by the study physician; Lack of German language skills as assessed by the study physician; Private health insurance; Other reasons that speak against participation in the intervention according to the assessment of the treating physician (e.g., patients with acute depression or psychosis); Participation in other studies should only take place after consultation with the treating physician

Design outcomes

Primary

MeasureTime frame
Number of protocol-defined pulmonary exacerbations during the entire observation period; Data collection time points: t0 = study enrollment; t1 = 1 weeks after study enrollment; t2 = 4 weeks after study enrollment; t3 = 3 months after study enrollment; t4 = 6 months after study enrollment; t5 = 9 months after study enrollment; t6 = 12 months after study enrollment

Secondary

MeasureTime frame
Number of COPD-associated hospitalizations per patient; Number of COPD-associated intensive care unit stays; Disease-related quality of life (Measured using the Saint George's Respiratory Questionnaire (SGRQ)); Health-related quality of life (Measured using the CAT score); Survey time points, respectively: t0 = study enrollment; t1 = 1 weeks after study enrollment; t2 = 4 weeks after study enrollment; t3 = 3 months after study enrollment; t4 = 6 months after study enrollment; t5 = 9 months after study enrollment; t6 = 12 months after study enrollment

Countries

Germany

Contacts

Public ContactHenrik Watz

LungenClinic Grosshansdorf

h.watz@pulmoresearch.de+49 41028881134

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026